{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:24:11Z","timestamp":1792265051110,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["RO1 MH104673"],"award-info":[{"award-number":["RO1 MH104673"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1038\/s41386-023-01541-3","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T10:03:18Z","timestamp":1676628198000},"page":"1060-1066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plasma and cerebrospinal fluid inflammatory markers and human aggression"],"prefix":"10.1038","volume":"48","author":[{"given":"Emil F.","family":"Coccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Royce","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"1541_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbi.2005.11.002","volume":"20","author":"JE Graham","year":"2006","unstructured":"Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R. Hostility and pain are related to inflammation. in older adults. Brain Behav Immun. 2006;20:389\u2013400.","journal-title":"Brain Behav Immun"},{"key":"1541_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/archinte.167.2.174","volume":"2007","author":"N Ranjit","year":"2007","unstructured":"Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, et al. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2007;2007:174\u201381.","journal-title":"Arch Intern Med"},{"key":"1541_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/01.psy.0000138281.73634.67","volume":"66","author":"EC Suarez","year":"2004","unstructured":"Suarez EC. C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med. 2004;66:684\u201391.","journal-title":"Psychosom Med"},{"key":"1541_CR4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jpsychires.2005.04.005","volume":"40","author":"EF Coccaro","year":"2006","unstructured":"Coccaro EF. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res. 2006;40:460\u20135.","journal-title":"J Psychiatr Res"},{"key":"1541_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbi.2007.11.008","volume":"22","author":"AL Marsland","year":"2008","unstructured":"Marsland AL, Prather AA, Petersen KL, Cohen S, Manuck SB. Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun. 2008;22:753\u201361.","journal-title":"Brain Behav Immun"},{"key":"1541_CR6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archpsyc.62.12.1377","volume":"62","author":"JK Kiecolt-Glaser","year":"2005","unstructured":"Kiecolt-Glaser JK, Loving TJ, Stowell JR, Malarkey WB, Lemeshow S, Dickinson SL, et al. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch Gen Psychiatry. 2005;62:1377\u201384.","journal-title":"Arch Gen Psychiatry"},{"key":"1541_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1023\/A:1026273817984","volume":"26","author":"GE Miller","year":"2003","unstructured":"Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med. 2003;26:501\u201315.","journal-title":"J Behav Med"},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbi.2005.08.001","volume":"20","author":"E Sjogren","year":"2006","unstructured":"Sjogren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: Studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behav Immun. 2006;20:270\u20138.","journal-title":"Brain Behav Immun"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/01.PSY.0000062530.94551.EA","volume":"65","author":"EC Suarez","year":"2003","unstructured":"Suarez EC. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med. 2003;65:523\u20137.","journal-title":"Psychosom Med"},{"key":"1541_CR10","first-page":"323","volume":"25","author":"M Pesce","year":"2011","unstructured":"Pesce M, Speranza L, Franceschelli S, Ialenti V, Patruno A, Febo MA, et al. Biological role of interleukin-1beta in defensive-aggressive behaviour. J Biol Regul Homeost Agents. 2011;25:323\u20139.","journal-title":"J Biol Regul Homeost Agents"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbi.2007.07.011","volume":"22","author":"S Bhatt","year":"2008","unstructured":"Bhatt S, Bhatt R, Zalcman SS, Siegel A. Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav Immunity. 2008;22:224\u201333.","journal-title":"Brain Behav Immunity."},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.bbi.2006.05.002","volume":"20","author":"SS Zalcman","year":"2006","unstructured":"Zalcman SS, Siegel A. The neurobiology of aggression and rage: role of cytokines. Brain Behav Immunity. 2006;20:507\u201314.","journal-title":"Brain Behav Immunity."},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.bbi.2010.05.005","volume":"24","author":"A Patel","year":"2010","unstructured":"Patel A, Siegel A, Zalcman SS. Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun. 2010;24:1276\u201380.","journal-title":"Brain Behav Immun."},{"key":"1541_CR14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Task Force on DSM-5: Diagnostic and Statistical Manual of Mental Disorders: DSM-5","author":"American Psychiatric Association, American Psychiatric Association.","year":"2013","unstructured":"American Psychiatric Association, American Psychiatric Association. Task Force on DSM-5: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association; 2013."},{"key":"1541_CR15","doi-asserted-by":"crossref","unstructured":"Coccaro EF, Lee RJ. Disordered Aggression and Violence in the United States. J Clin Psychiatry. 2020;81:e1\u2013e8.","DOI":"10.4088\/JCP.19m12937"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/npp.2009.148","volume":"35","author":"EF Coccaro","year":"2010","unstructured":"Coccaro EF, Lee R, Kavoussi RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010;35:435\u201344.","journal-title":"Neuropsychopharmacology."},{"key":"1541_CR17","first-page":"32","volume":"1","author":"EF Coccaro","year":"2016","unstructured":"Coccaro EF, Fitzgerald DA, Lee R, McCloskey M, Phan KL. Frontolimbic morphometric abnormalities in intermittent explosive disorder and aggression. Biol Psychiatry. 2016;1:32\u20138.","journal-title":"Biol Psychiatry"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biopsych.2006.08.024","volume":"62","author":"EF Coccaro","year":"2007","unstructured":"Coccaro EF, McCloskey MS, Fitzgerald DA, Phan KL. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol Psychiatry. 2007;62:168\u201378.","journal-title":"Biol Psychiatry"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpsychires.2016.04.006","volume":"79","author":"MS McCloskey","year":"2016","unstructured":"McCloskey MS, Phan KL, Angstadt M, Fettich KC, Keedy S, Coccaro EF. Amygdala hyperactivation to angry faces in intermittent explosive disorder. J Psychiatr Res. 2016;79:34\u201341.","journal-title":"J Psychiatr Res"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamapsychiatry.2013.3297","volume":"71","author":"EF Coccaro","year":"2014","unstructured":"Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2014;71:158\u201365.","journal-title":"JAMA Psychiatry"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.comppsych.2012.03.007","volume":"53","author":"EF Coccaro","year":"2012","unstructured":"Coccaro EF, Nayyer H, McCloskey MS. Personality disorder-not otherwise specified evidence of validity and consideration for DSM-5. Compr Psychiatry. 2012;53:907\u201314.","journal-title":"Compr Psychiatry"},{"key":"1541_CR22","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York: Psychiatric Institute, Biometrics Research; 1997."},{"key":"1541_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0165-1781(97)00119-4","volume":"73","author":"EF Coccaro","year":"1997","unstructured":"Coccaro EF, Berman ME, Kavoussi RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res. 1997;73:147\u201357.","journal-title":"Psychiatry Res"},{"key":"1541_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","volume":"63","author":"AH Buss","year":"1992","unstructured":"Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63:452\u20139.","journal-title":"J Pers Soc Psychol"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jpsychires.2011.11.008","volume":"46","author":"EF Coccaro","year":"2012","unstructured":"Coccaro EF, Schmidt-Kaplan CA. Life history of impulsive behavior: development and validation of a new questionnaire. J Psychiatr Res. 2012;46:346\u201352.","journal-title":"J Psychiatr Res"},{"key":"1541_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"J Patton","year":"1995","unstructured":"Patton J, Stanford M, Barratt E. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768\u201374.","journal-title":"J Clin Psychol"},{"key":"1541_CR27","volume-title":"Beck Depression Inventory-II (BDI-II)","author":"AT Beck","year":"1996","unstructured":"Beck AT, Brown GK. Beck Depression Inventory-II (BDI-II). San Antonio, TX.: The Psychological Corporation; 1996."},{"key":"1541_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"1541_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:386\u201396.","journal-title":"J Health Soc Behav"},{"key":"1541_CR30","volume-title":"Four factor index of social status","author":"AB Hollingshead","year":"1975","unstructured":"Hollingshead AB. Four factor index of social status. New Haven, CT: Yale University; 1975. Unpublished Manuscript"},{"key":"1541_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4088\/JCP.v64n0614","volume":"64","author":"MR Kraus","year":"2003","unstructured":"Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry. 2003;64:708\u201314.","journal-title":"J Clin Psychiatry"},{"key":"1541_CR32","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"J McHuthison","year":"1998","unstructured":"McHuthison J, Gordon S, Schiff E. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. NEJM 1998;339:1485\u201392.","journal-title":"NEJM"},{"key":"1541_CR33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.psyneuen.2004.01.002","volume":"29","author":"EC Suarez","year":"2004","unstructured":"Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology. 2004;29:1119\u201328.","journal-title":"Psychoneuroendocrinology."},{"key":"1541_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"key":"1541_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","volume":"25","author":"JC Felger","year":"2020","unstructured":"Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry. 2020;25:1301\u201311.","journal-title":"Mol Psychiatry"},{"key":"1541_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S2215-0366(20)30255-8","volume":"7","author":"JH Meyer","year":"2020","unstructured":"Meyer JH, Cervenka S, Kim MJ, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020;7:1064\u201374.","journal-title":"Lancet Psychiatry"},{"key":"1541_CR37","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1016\/j.biopsych.2014.09.023","volume":"78","author":"NA Harrison","year":"2015","unstructured":"Harrison NA, Cooper E, Dowell NG, Keramida G, Voon V, Critchley HD, et al. Quantitative magnetization transfer imaging as a biomarker for effects of systemic inflammation on the brain. Biol Psychiatry. 2015;78:4957.","journal-title":"Biol Psychiatry"},{"key":"1541_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.biopsych.2008.04.016","volume":"64","author":"AL Marsland","year":"2008","unstructured":"Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry. 2008;64:484\u201390.","journal-title":"Biol Psychiatry"},{"key":"1541_CR39","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","volume":"21","author":"JC Felger","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21:1358\u201365.","journal-title":"Mol Psychiatry"},{"key":"1541_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.bbi.2018.07.026","volume":"73","author":"ND Mehta","year":"2018","unstructured":"Mehta ND, Haroon E, Xu X, Woolwine BJ, Li L, Felger JC. Inflammation negatively correlates with amygdala-ventromedial prefrontal functional connectivity in association with anxiety in patients with depression: preliminary results. Brain Behav Immun. 2018;73:725\u201330.","journal-title":"Brain Behav Immun"},{"key":"1541_CR41","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1016\/j.neuroimage.2011.10.090","volume":"59","author":"TK Inagaki","year":"2012","unstructured":"Inagaki TK, Muscatell KA, Irwin MR, Cole SW, Eisenberger NI. Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage. 2012;59:3222\u20136.","journal-title":"Neuroimage."},{"key":"1541_CR42","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/hbm.22063","volume":"34","author":"JS Kullmann","year":"2013","unstructured":"Kullmann JS, Grigoleit JS, Lichte P, Kobbe P, Rosenberger C, Banner C, et al. Neural response to emotional stimuli during experimental human endotoxemia. Hum Brain Mapp. 2013;34:2217\u201327.","journal-title":"Hum Brain Mapp"},{"key":"1541_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9:46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"1541_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immunol. 2007;21:727\u201335.","journal-title":"Brain Behav Immunol"},{"key":"1541_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0306-4522(03)00264-1","volume":"120","author":"M Hassanain","year":"2003","unstructured":"Hassanain M, Zalcman S, Bhatt S, Siegel A. Interleukin-1 beta in the hypothalamus potentiates feline defensive rage: role of serotonin-2 receptors. Neuroscience. 2003;120:227\u201333.","journal-title":"Neuroscience."},{"key":"1541_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2005.04.086","volume":"1048","author":"M Hassanain","year":"2005","unstructured":"Hassanain M, Bhatt S, Zalcman S, Siegel A. Potentiating role of interleukin-1beta (IL-1beta) and IL-1beta type 1 receptors in the medial hypothalamus in defensive rage behavior in the cat. Brain Res. 2005;1048:1\u201311.","journal-title":"Brain Res"},{"key":"1541_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbr.2005.09.011","volume":"167","author":"S Bhatt","year":"2006","unstructured":"Bhatt S, Siegel A. Potentiating role of interleukin 2 (IL-2) receptors in the midbrain periaqueductal gray (PAG) upon defensive rage behavior in the cat: role of neurokinin NK(1) receptors. Behav Brain Res. 2006;167:251\u201360.","journal-title":"Behav Brain Res"},{"key":"1541_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuroscience.2005.01.065","volume":"133","author":"S Bhatt","year":"2005","unstructured":"Bhatt S, Zalcman S, Hassanain M, Siegel A. Cytokine modulation of defensive rage behavior in the cat: role of GABAA and interleukin-2 receptors in the medial hypothalamus. Neuroscience. 2005;133:17\u201328.","journal-title":"Neuroscience."},{"key":"1541_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jad.2018.09.005","volume":"243","author":"HB Chang","year":"2019","unstructured":"Chang HB, Munroe S, Gray K, Porta G, Douaihy A, Marsland A, et al. The role of substance use, smoking, and inflammation in risk for suicidal behavior. J Affect Disord. 2019;243:33\u201341.","journal-title":"J Affect Disord"},{"key":"1541_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jpsychires.2018.09.004","volume":"106","author":"W Coryell","year":"2018","unstructured":"Coryell W, Wilcox H, Evans SJ, Pandey GN, Jones-Brando L, Dickerson F, et al. Aggression, impulsivity and inflammatory markers as risk factors for suicidal behavior. Psychiatry Res. 2018;106:38\u201342.","journal-title":"Psychiatry Res"},{"key":"1541_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1037\/pag0000348","volume":"34","author":"MA Barlow","year":"2019","unstructured":"Barlow MA, Wrosch C, Gouin J-P, Kunzmann U. Is anger, but not sadness, associated with chronic inflammation and illness in older adulthood? Psychol Aging. 2019;34:330\u201340.","journal-title":"Psychol Aging"},{"key":"1541_CR52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1037\/hea0001029","volume":"40","author":"JC Yong","year":"2021","unstructured":"Yong JC, Hartanto A, Tan JJX. Subjective social status and inflammation: The role of culture and anger control. Health Psychol. 2021;40:62\u201370.","journal-title":"Health Psychol"},{"key":"1541_CR53","first-page":"31","volume-title":"Aggression: Clinical Features and Treatment Across the Diagnostic Spectrum","author":"MS McCloskey","year":"2019","unstructured":"McCloskey MS, Fahlgren MK, Coccaro EF. Assessment and treatment of intermittent explosive disorder. In: Coccaro EF, McCloskey MS, Eds. Aggression: Clinical Features and Treatment Across the Diagnostic Spectrum. Washington, D.C.: American Psychiatric Association Publishing; 2019. p. 31\u201349."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01541-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01541-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T14:03:17Z","timestamp":1684936997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-023-01541-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1038\/s41386-023-01541-3","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,17]]},"assertion":[{"value":"15 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EFC reports being a consultant to and being on the Scientific Advisory Boards of Azevan Pharmaceuticals, Inc., Avanir Pharmaceuticals, Inc., Boerhinger Ingelheim, Pharma, Inc., and being a current recipient of a grant award from the NIMH and NIAAA. RL, ECB, and MRI report no biomedical financial interests or competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}